Patents by Inventor Heiko Mattern

Heiko Mattern has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240041940
    Abstract: The present invention provides novel compositions comprising multipotent cells or microvascular tissue, wherein the cells or tissue has been sterilized and/or treated to inactivated viruses, and related methods of using these compositions to treat or prevent tissue injury or disease in an allogeneic subject.
    Type: Application
    Filed: October 13, 2023
    Publication date: February 8, 2024
    Inventors: Dale R. PETERSON, Ralph-Heiko MATTERN, Kevin L. OHASHI, Lael J. PICKETT, Glen GONG, Mohammad A. EL-KALAY
  • Patent number: 11819522
    Abstract: The present invention provides novel compositions comprising multipotent cells or microvascular tissue, wherein the cells or tissue has been sterilized and/or treated to inactivated viruses, and related methods of using these compositions to treat or prevent tissue injury or disease in an allogeneic subject.
    Type: Grant
    Filed: January 4, 2022
    Date of Patent: November 21, 2023
    Assignee: MicroVascular Tissues, Inc.
    Inventors: Dale R. Peterson, Ralph-Heiko Mattern, Kevin L Ohashi, Lael J. Pickett, Glen Gong, Mohammad A. El-Kalay
  • Publication number: 20220323508
    Abstract: The present invention provides novel compositions comprising multipotent cells or microvascular tissue, wherein the cells or tissue has been sterilized and/or treated to inactivated viruses, and related methods of using these compositions to treat or prevent tissue injury or disease in an allogeneic subject.
    Type: Application
    Filed: January 4, 2022
    Publication date: October 13, 2022
    Inventors: Dale R. PETERSON, Ralph-Heiko MATTERN, Kevin L. OHASHI, Lael J. PICKETT, Glen GONG, Mohammad A. EL-KALAY
  • Patent number: 11246891
    Abstract: The present invention provides novel compositions comprising multipotent cells or microvascular tissue, wherein the cells or tissue has been sterilized and/or treated to inactivated viruses, and related methods of using these compositions to treat or prevent tissue injury or disease in an allogeneic subject.
    Type: Grant
    Filed: February 3, 2020
    Date of Patent: February 15, 2022
    Assignee: Micro Vascular Tissues, Inc.
    Inventors: Dale R. Peterson, Ralph-Heiko Mattern, Kevin L. Ohashi, Lael J. Pickett, Glen Gong, Mohammad A. El-Kalay
  • Publication number: 20200353008
    Abstract: The disclosure relates to new compositions for the treatment of neuropathy. The compositions of the disclosure provide increased efficacy in the treatment of diabetic neuropathy when applied topically to diabetic ulcers.
    Type: Application
    Filed: January 8, 2019
    Publication date: November 12, 2020
    Inventors: Dale R. PETERSON, Kevin L. OHASHI, Lael J. PICKETT, Glen GONG, Mohammad A. EL-KALAY, Ralph-Heiko MATTERN
  • Publication number: 20200323925
    Abstract: The present invention provides novel compositions comprising multipotent cells or microvascular tissue, wherein the cells or tissue has been sterilized and/or treated to inactivated viruses, and related methods of using these compositions to treat or prevent tissue injury or disease in an allogeneic subject.
    Type: Application
    Filed: February 3, 2020
    Publication date: October 15, 2020
    Inventors: Dale R. PETERSON, Ralph-Heiko MATTERN, Kevin L. OHASHI, Lael J. PICKETT, Glen GONG, Mohammad A. EL-KALAY
  • Patent number: 10729729
    Abstract: The present invention provides novel compositions comprising multipotent cells or microvascular tissue, wherein the cells or tissue has been sterilized and/or treated to inactivated viruses, and related methods of using these compositions to treat or prevent tissue injury or disease in an allogeneic subject.
    Type: Grant
    Filed: June 26, 2017
    Date of Patent: August 4, 2020
    Assignee: MicroVascular Tissues, Inc.
    Inventors: Dale R. Peterson, Ralph-Heiko Mattern, Corey Wilson-Wirth, Kevin L. Ohashi
  • Patent number: 10617792
    Abstract: The present invention provides novel compositions comprising multipotent cells or microvascular tissue, wherein the cells or tissue has been sterilized and/or treated to inactivated viruses, and related methods of using these compositions to treat or prevent tissue injury or disease in an allogeneic subject.
    Type: Grant
    Filed: January 2, 2018
    Date of Patent: April 14, 2020
    Assignee: MicroVascular Tissues, Inc.
    Inventors: Dale R. Peterson, Ralph-Heiko Mattern, Corey Wilson, Kevin L. Ohashi
  • Patent number: 10596202
    Abstract: The present invention provides novel compositions comprising multipotent cells or microvascular tissue, wherein the cells or tissue has been sterilized and/or treated to inactivated viruses, and related methods of using these compositions to treat or prevent tissue injury or disease in an allogeneic subject.
    Type: Grant
    Filed: January 8, 2018
    Date of Patent: March 24, 2020
    Assignee: MicroVascular Tissues, Inc.
    Inventors: Dale R. Peterson, Ralph-Heiko Mattern, Kevin L. Ohashi, Lael J. Pickett, Glen Gong, Mohammad A. El-Kalay
  • Publication number: 20190091261
    Abstract: The present disclosure provides compositions with enhanced bioactivity and methods of use in the treatment of disease or tissue injury and pain associated with disease conditions.
    Type: Application
    Filed: March 2, 2017
    Publication date: March 28, 2019
    Inventors: Dale R. PETERSON, Ralph-Heiko MATTERN, Douglas M. ARM, Lael J. PICKETT, Glen GONG, Kevin L. OHASHI
  • Publication number: 20180161379
    Abstract: The present invention provides novel compositions comprising multipotent cells or microvascular tissue, wherein the cells or tissue has been sterilized and/or treated to inactivated viruses, and related methods of using these compositions to treat or prevent tissue injury or disease in an allogeneic subject.
    Type: Application
    Filed: January 8, 2018
    Publication date: June 14, 2018
    Inventors: Dale R. PETERSON, Ralph-Heiko MATTERN, Corey WILSON, Kevin L. OHASHI, Lael J. PICKETT, Glen GONG, Mohammad A. EL-KALAY
  • Publication number: 20180133371
    Abstract: The present invention provides novel compositions comprising multipotent cells or microvascular tissue, wherein the cells or tissue has been sterilized and/or treated to inactivated viruses, and related methods of using these compositions to treat or prevent tissue injury or disease in an allogeneic subject.
    Type: Application
    Filed: January 2, 2018
    Publication date: May 17, 2018
    Inventors: Dale R. PETERSON, Ralph-Heiko MATTERN, Corey WILSON, Kevin L. OHASHI
  • Patent number: 9872937
    Abstract: The present invention provides novel compositions comprising multipotent cells or microvascular tissue, wherein the cells or tissue has been sterilized and/or treated to inactivated viruses, and related methods of using these compositions to treat or prevent tissue injury or disease in an allogeneic subject.
    Type: Grant
    Filed: May 6, 2016
    Date of Patent: January 23, 2018
    Assignee: Microvascular Tissues, Inc.
    Inventors: Dale R. Peterson, Ralph-Heiko Mattern, Cory Wilson-Wirth, I, Kevin L. Ohashi
  • Publication number: 20170360845
    Abstract: The present invention provides novel compositions comprising multipotent cells or microvascular tissue, wherein the cells or tissue has been sterilized and/or treated to inactivated viruses, and related methods of using these compositions to treat or prevent tissue injury or disease in an allogeneic subject.
    Type: Application
    Filed: June 26, 2017
    Publication date: December 21, 2017
    Inventors: Dale R. PETERSON, Ralph-Heiko Mattern, Corey Wilson-Wirth, Kevin L. Ohashi
  • Patent number: 9713629
    Abstract: The present invention provides novel compositions comprising multipotent cells or microvascular tissue, wherein the cells or tissue has been sterilized and/or treated to inactivated viruses, and related methods of using these compositions to treat or prevent tissue injury or disease in an allogeneic subject.
    Type: Grant
    Filed: September 17, 2013
    Date of Patent: July 25, 2017
    Assignee: MicroVascular Tissues, Inc.
    Inventors: Dale R. Peterson, Ralph-Heiko Mattern, Corey Wilson-Wirth, Kevin L. Ohashi
  • Publication number: 20160271187
    Abstract: The present invention provides novel compositions comprising multipotent cells or microvascular tissue, wherein the cells or tissue has been sterilized and/or treated to inactivated viruses, and related methods of using these compositions to treat or prevent tissue injury or disease in an allogeneic subject.
    Type: Application
    Filed: May 6, 2016
    Publication date: September 22, 2016
    Inventors: Dale R. PETERSON, Ralph-Heiko MATTERN, Cory WILSON-WIRTH, I, Kevin L. OHASHI
  • Publication number: 20150231183
    Abstract: The present invention provides novel compositions comprising multipotent cells or microvascular tissue, wherein the cells or tissue has been sterilized and/or treated to inactivated virases, and related methods of using these compositions to treat or prevent tissue injury or disease in an allogeneic subject.
    Type: Application
    Filed: September 17, 2013
    Publication date: August 20, 2015
    Inventors: Dale R. Peterson, Ralph-Heiko Mattern, Corey Wilson-Wirth, Kevin L. Ohashi
  • Publication number: 20080087689
    Abstract: A decanter and doser for liquids, in particular for wine, comprising an adapter (11) for the mouth of a bottle (16) from which a T-terminating tubular element (12) extends, of which one end is equipped with an outward opening (17), with a possible closing (15), and an opposite end has an enlarged element (19) for the closed containment of a pre-established volume.
    Type: Application
    Filed: March 23, 2005
    Publication date: April 17, 2008
    Inventors: Heiko Mattern, Damiano Miniera
  • Publication number: 20060008905
    Abstract: Compositions of cross-linked collagen and a glycosaminoglycan are provided which retain characteristics rendering them useful as tissue engineering matrices or scaffolds following terminal sterilization. Also provided are methods for producing these compositions and terminally sterilized matrices or scaffolds from these compositions as well as methods of using these matrices or scaffolds as tissue engineering devices.
    Type: Application
    Filed: September 9, 2005
    Publication date: January 12, 2006
    Inventors: Ralph-Heiko Mattern, Michael Pierschbacher, Fred Cahn, Juerg Tschopp, Timothy Malaney
  • Patent number: 6969523
    Abstract: Compositions of cross-linked collagen and a glycosaminoglycan are provided which retain characteristics rendering them useful as tissue engineering matrices or scaffolds following terminal sterilization. Also provided are methods for producing these compositions and terminally sterilized matrices or scaffolds from these compositions as well as methods of using these matrices or scaffolds as tissue engineering devices.
    Type: Grant
    Filed: October 19, 2001
    Date of Patent: November 29, 2005
    Assignee: Integra LifeSciences Corporation
    Inventors: Ralph-Heiko Mattern, Michael D. Pierschbacher, Fred Cahn, Juerg Friederich Tschopp, Timothy Irvin Malaney